Type 2 diabetes: open trials in Spain

57 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT07595549
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Trial Treatment · Phase 3 · Pfizer
Instituto Medico Quirurgico San Rafael S.A., A Coruna · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-05
NCT07668336
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Regional de Málaga, Málaga · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-05
NCT07282600
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Universitario de La Ribera, Alzira · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Hospital Ruber Juan Bravo, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Regional de Málaga, Málaga · University Hospital Virgen Del Rocio S.L., Sevilla · Centro Médico Compostela
Registry updated 2026-11-04
NCT07392190
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Trial Treatment · Phase 3 · Eli Lilly and Company
Instituto Medico Quirurgico San Rafael S.A., A Coruna · Hospital Universitario Torrecárdenas, Almería · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Instituto Gallego de Cirugía Ocular, Ferrol · Clinica Juaneda S.A., Palma · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Quironsalud Infanta Luisa, Sevilla · Nuevas Tecnologias En Diabetes Y En Endocrinologia S.L. Profesional, Sevilla
Registry updated 2026-11-04
NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
CHUAC-Complejo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario de La Ribera, Alzira · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Complejo Hospitalario Universitario de Ferrol (CHUF)- Hospital Naval, Ferrol · Hospital Vithas La Salud, Granada · H.R.U Málaga - Hospital Civil, Málaga · Hospital Universitario Virgen del Rocio, Seville · Vithas Hospital Sevilla, Seville
Registry updated 2026-11-04
NCT07900633
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Trial Treatment · Phase 3 · Eli Lilly and Company
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario de La Ribera, Alzira · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Area Sanitaria De Ferrol, Ferrol · Hospital Vithas La Salud, Granada · Hospital Polusa S.A., Lugo · Hospital Universitario La Paz, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · University Hospital Son Espases, Palma · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla · Nuevas Tecnologias En Diabetes Y En Endocrinologia S.L. Profesional, Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-03
2026-525472-26-00
AMBITION 3: A research study investigating how well zenagamtide at higher dose levels lowers blood sugar and body weight compared to semaglutide in people with type 2 diabetes treated with metformin, SGLT2i, or both
Trial Treatment · Phase 3 · Novo Nordisk A/S
Centro Periférico de Especialidades Bola Azul, Almería · Consorci D'atencio Primaria De Salut Barcelona Esquerra, Barcelona · Centre d'Atenció Primària Sarrià, Barcelona · Centre d'Atenció Primària Canet de Mar, Barcelona · Eba Vallcarca Slp, Barcelona · Centro De Salud Cabra Matrona Antonia Mesa Fernandez, Cabra · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Centro de Salud San Juan de la Cruz, Pozuelo de Alarcón · CAP Turó de Can Mates, San Cugat del Vallés · Centro de Salud La Cuesta, Santa Cruz de Tenerife · Hospital Universitario Marqués de Valdecilla, Santander · Equip D'assistencia Primaria Vic S.L.P., Vic
Registry updated 2026-11-02
NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Trial Treatment · Phase 3 · Boehringer Ingelheim
Hospital Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · CAP La Mina, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Hospital de Galdakao-Usansolo, Galdakao · Hospital Universitario Virgen de las Nieves, Granada · Hospital Infanta Elena, Huelva · Hospital Universitario de Jaén, Jaén · El Hospital Universitario De Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria · Hospital Universitario Infanta Leonor, Madrid · Hospital Universitario de la Princesa, Madrid · Parc Tauli Hospital Universitari, Sabadell · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario de Toledo, Toledo · Consorcio Hospital General Universitario de Valencia, Valencia · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Rio Hortega, Valladolid · Complexo Hospitalario Universitario De Vigo, Vigo · Hospital Virgen de las Montañas, Villamartín
Registry updated 2026-10-28
NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Trial Treatment · Phase 3 · AstraZeneca
A Coruña · Alzira (Valencia) · Barcelona · Castilleja de La Cuesta, Sevilla · Ferrol (A Coruña) · Lleida · Málaga · Oviedo · Segovia · Seville
Registry updated 2026-10-28
NCT07285330
Dietitian-Nutritionist vs. Day Hospital in the Metabolic Control of Patients With Type 2 Diabetes
Research · Consorci Sanitari de l'Alt Penedès i Garraf
Hospital de Vilafranca, Vilafranca del Penedès
Registry updated 2026-10-27
2026-525474-20-00
AMBITION 4: A research study investigating how well zenagamtide at lower dose levels lowers blood sugar and body weight compared to semaglutide at lower dose levels in people with type 2 diabetes treated with metformin, SGLT2i, or both
Trial Treatment · Phase 3 · Novo Nordisk A/S
Equip D'atencio Primaria Barcelona Sardenya S.L.P., Barcelona · Clinica Bofill S.L., Girona · CAP Alhambra, L'Hospitalet de Llobregat (Barcelona) · CS Monzón Urbano, Monzón · Area De Salud De Salamanca, Salamanca · Hospital Quironsalud Infanta Luisa, Sevilla
Registry updated 2026-10-26
NCT07373938
Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus
Research · Cardenal Herrera University
Francisco Javier Molina Payá, Elche
Registry updated 2026-10-20
NCT07554469
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-10-14
NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Instituto Medico Quirurgico San Rafael S.A., A Coruna · Hospital del Mar, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Hospital Clínico San Carlos, Madrid · Hospital Ruber Juan Bravo, Madrid · Clínica Universidad de navarra, Pamplona · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Quironsalud Infanta Luisa, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-10-13
NCT07351058
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Germans Trias i Pujol, Badalona · Centro Medico Teknon - Grupo Quironsalud, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Area Sanitaria De Ferrol, Ferrol · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Nuevas Tecnologias En Diabetes Y En Endocrinologia S.L. Profesional, Sevilla
Registry updated 2026-10-13
NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Trial Treatment · Phase 3 · AstraZeneca
A Coruña · Almería · Badalona · Barcelona · León · Madrid · Santander · Santiago de Compostela · Seville · Tarragona · Valencia
Registry updated 2026-10-13
2025-524616-11-00
A Study to evaluate effect of AZD6234 in adult participants with Type 2 Diabetes Mellitus and obesity or overweight
Trial Treatment · Phase 3 · AstraZeneca AB
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario de La Ribera, Alzira · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Area Sanitaria De Ferrol, Ferrol · Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida, Lleida · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Central De Asturias, Oviedo · Hospital General de Segovia, Segovia · Hospital Quironsalud Infanta Luisa, Sevilla
Registry updated 2026-10-09
NCT07668388
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Trial Treatment · Phase 2 · Novo Nordisk A/S
Hospital Universitari Vall d'Hebron, Barcelona · EAP Osona Sud - Alt Congost S.L.P, Centelles · Hospital Universitario de la Princesa, Madrid · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Quironsalud Infanta Luisa, Sevilla · Equip D'assistencia Primaria Vic S.L.P., Vic
Registry updated 2026-10-07
2026-526953-32-00
Impact of Semaglutide in Liver Transplant Candidates with Obesity (SOMAL Study): A Prospective Randomized Study.
Trial Treatment · Phase 3 · Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
University Clinical Hospital Virgen De La Arrixaca, Murcia
Registry updated 2026-10-02
NCT07564414
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Trial Treatment · Phase 3 · Novo Nordisk A/S
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital de Antequera, Antequera · Hospital Universitari Vall d'Hebron, Barcelona · Consorci D'atencio Primaria De Salut Barcelona Esquerra, Barcelona · EAP Osona Sud - Alt Congost S.L.P, Centelles · Hospital Universitario de Fuenlabrada, Fuenlabrada · Clinica Bofill S.L., Girona · Hospital Ruber Juan Bravo, Madrid · Hospital Universitario Sanitas Virgen del Mar, Madrid · Hospital Universitario de la Princesa, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Althaia Xarxa Assistencial Universitaria De Manresa Fundacio Privada, Manresa · Hospital Recoletas Campo Grande, Valladolid
Registry updated 2026-09-30
NCT05663515
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Research · AstraZeneca
Barcelona
Registry updated 2026-09-24
NCT07828847
Involvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise
Trial Treatment · Fundación para la Investigación del Hospital Clínico de Valencia
University of Valencia/Hospital Clínico Universitario de València,, Valencia
Registry updated 2026-09-18
NCT07415954
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Trial Treatment · Phase 2 · Novo Nordisk A/S
Centro de Salud A Estrada, A Estrada · Projectes Sanitaris I Socials S.A., Barcelona · Equip D'atencio Primaria Barcelona Sardenya S.L.P., Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Clinica Bofill S.L., Girona · Centro de Saúde Concepción Arenal, Santiago de Compostela
Registry updated 2026-09-11
2025-524688-19-00
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
Trial Treatment · Phase 3 · AstraZeneca AB
Instituto Medico Quirurgico San Rafael S.A., A Coruna · Centro Periférico de Especialidades Bola Azul, Almería · Hospital Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Nisa Sevilla Aljarafe, Castilleja De La Cuesta · Hospital Universitario De Leon, León · Hospital Ruber Juan Bravo, Madrid · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Provincial de Conxo, Santiago de Compostela · Nuevas Tecnologias En Diabetes Y En Endocrinologia S.L. Profesional, Sevilla · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitari Joan XXIII de Tarragona, Tarragona · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-09-08
2025-524606-15-00
Study of a DPP 4 inhibitor and an SGLT2 inhibitor used together compared with each treatment alone in adults with type 2 diabetes treated with metformin.
Trial Treatment · Phase 3 · Tecnimede-Sociedade Tecnico-Medicinal S.A.
Futuremeds Spain S.L., Chiclana De La Frontera · Instituto Gallego de Cirugía Ocular, Ferrol · Hospital Universitario Juan Ramon Jimenez, Huelva · Futuremeds Spain S.L., Madrid · Hospital Universitario Regional de Málaga, Málaga · Complejo Asistencial Universitario de Salamanca, Salamanca · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · Hospital Universitario San Juan de Alicante, Sant Joan d'Alacant · Futuremeds Spain S.L., Sevilla · Hospital Universitario de Toledo, Toledo · Hospital Universitario Rio Hortega, Valladolid
Registry updated 2026-09-04

All Type 2 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error